Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - Tian Zhang
@tiansterzhangmd.bsky.social
oncodaily.com/insight/nico...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ProstateCancer
@tiansterzhangmd.bsky.social
I treat & research GU cancers @UTSW in Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Posts=my opinions ASCO COI: https://coi.asco.org/share/3UF-6U3Z/Tian%20Zhang
Great Editorial Led by Nicolas Sayegh on Subsets of Prostate Cancer - Tian Zhang
@tiansterzhangmd.bsky.social
oncodaily.com/insight/nico...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ProstateCancer
π₯Results from PDIGREE: ipi + nivo in mccRCC shows consistent safety & early CRs in a diverse U.S. population
@tiansterzhangmd.bsky.social shares insights from #ASCO25
β‘οΈhttps://buff.ly/o2oUojfβ¬
οΈ
@ASCO #kcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ImmunoOnc
#ShahneenSandhu on collaborative efforts with industry partners - how do we maximize time & effort to make industry supported IITs and large phase 3 trials for clinical development. @anzuptrials.bsky.social #ANZUP25
19.07.2025 23:45 β π 4 π 1 π¬ 0 π 0@profiand.bsky.social with key insights to large trial and grant funding in Australia β trial impact, equity in diverse populations, cost effectiveness, patient advocate/consumer involvement, and feasibility @anzuptrials.bsky.social #ANZUP25
19.07.2025 23:28 β π 2 π 1 π¬ 0 π 0Great kickoff to clinical trials workshop #ANZUP25 β #MelissaLeMesurier w patient perspective and #ChrisGianacas biostats on collaborative efforts for clinical trials. Same global themes for clinical trial development. @anzuptrials.bsky.social @craiggedye.bsky.social @profiand.bsky.social
19.07.2025 23:19 β π 4 π 2 π¬ 0 π 0Pleasure to highlight your work with #UroToday @ravimadan.bsky.social - as we all consider how best to treat PSMA avid disease.
19.07.2025 23:17 β π 5 π 1 π¬ 0 π 0Proud of our #UTSWcancer clinical research teams displaying our cancer centerβs ongoing work in clinical trials @aacicancer.bsky.social #CRI25 meeting today! Clinical trials are essential to improving outcomes for our patients with cancer - here to network & learn best practices!
24.06.2025 02:45 β π 2 π 0 π¬ 0 π 0I categorically refuse to accept either of these as normal or routine.
www.nytimes.com/2025/06/14/u...
See our #Urotoday recording with David Wise on this promising trial in #prostatecancer reported at #ASCO25!
urldefense.com/v3/__https:/...
New from #ASCO25: Final results of CheckMate-214 show that nivo + ipi continues to improve OS compared with sunitinib for previously untreated advanced RCC: dailynews.ascopubs.org/do/checkmate... #ASCODailyNews @mskcancercenter.bsky.social @tiansterzhangmd.bsky.social
01.06.2025 17:49 β π 3 π 1 π¬ 0 π 1The connections built within ASCO transcend our daily institutions, across borders, across disease types. We are in this together and we will come out stronger for it β we must, for our patients. See yβall soon @ascocancer.bsky.social #ASCO25 #FIN
30.05.2025 11:53 β π 1 π 0 π¬ 0 π 0Am looking forward to seeing & meeting our colleagues from around the world, adding our knowledge gained, and contributing in my role @utswcancer to our cancer research fields. @ascocancer.bsky.social #ASCO25
30.05.2025 11:53 β π 1 π 0 π¬ 1 π 0We celebrate early career investigators who will make new discoveries to push the field. Even as federal funding decreases, now more than ever we depend on foundations like @ConquerCancerFd @kidneycancer @kccure for this new generation of minds hard at work. @ASCO #ASCO25
30.05.2025 11:52 β π 0 π 0 π¬ 1 π 0The global community comes together for 5 days #ASCO25 to share our work and our advances for our patients. Cancer knows no boundaries and knowledge will empower each of us in daily work ahead. @ASCO
30.05.2025 11:52 β π 1 π 0 π¬ 1 π 0Thatβs what we all want with this brief time on earth β More time to be productive. More time to see the world. More time with loved ones. @ASCO #ASCO25
30.05.2025 11:51 β π 0 π 0 π¬ 1 π 0At the center of next few days @asco #Asco25: our patients. And β if we face our humanity, ourselves βas we age & deal w/ cancer. Nothing harder in my clinic than telling a patient βthere are no more treatment optionsβ. Every trial gives hope & every new drug gives more time. 2/n
30.05.2025 11:50 β π 0 π 0 π¬ 1 π 0Traveling w/ mixed emotions to @asco #asco25 this yr. Celebrating science & the yrs of dedication, work, & patient contributions to cancer clinical trials. But science itself is under attack β defunding of preclinical discovery work will end up slowing our clinical advances. 1/n
30.05.2025 11:50 β π 2 π 2 π¬ 1 π 0Our hearts go out to the Biden family. Metastatic prostate cancer is common but hard. They will face many treatment decisions ahead. apple.news/Ai-QLq9onRNW...
19.05.2025 03:27 β π 1 π 0 π¬ 0 π 0Women in RCC Negotiations Spotlight at IKCSEU25 - Tian Zhang
@tiansterzhangmd.bsky.social
@drnataliagandur.bsky.social
@kidney-cancer.bsky.social
oncodaily.com/blog/tian-zh...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #IKCSEU25 #RCC #IKCS25 #WomenInRCC
Plenary session with @MarcelaMaus @MGHCancerCenter on future CAR-T cells β setting vision toward personalized, patient centered approaches to find the right CARTs. #AACR25 @oncoalert.bsky.social @theaacr.bsky.social
28.04.2025 14:08 β π 1 π 1 π¬ 0 π 0Hey all my #Cansky and especially #Kidneycancer folks, check out this awesome episode from @lauraesfeller.bsky.social and Judy Nicholson Foundation featuring @tiansterzhangmd.bsky.social. Fantastic episodeππ»ππ».
youtu.be/25TXzH5suio?...
A great start to #UTChrisWood25 - localized RCC discussions from diagnosis (ccRCC score) & novel tracers to treatment of surgery, SBRT, & ablation. #IvanPedrosa #ChadTang #JoseKaram #IsamuTachibana #mohamedabdelsalam & interactive panel discussion!
04.04.2025 17:33 β π 0 π 0 π¬ 0 π 0Best practices for second line treatment in Metastatic Urothelial Carcinoma - @tiansterzhangmd.bsky.social .bsky.social
oncodaily.com/url/267046
#GUOnc #UrothelialCarcinoma #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer
Also welcome, glad youβre here on Bluesky π€
20.02.2025 00:46 β π 0 π 0 π¬ 0 π 0Have added you to my bladder-kidney cancer starter pack! Likely @ravimadan.bsky.social would add you to the prostate cancer one too!
20.02.2025 00:46 β π 2 π 0 π¬ 1 π 1Give both recs and have patient decide!
14.02.2025 17:59 β π 1 π 0 π¬ 1 π 0@erplimackmd.bsky.social with killer discussion setting the scene for the #NIAGARA βsandwichβ & #Checkmate274, both practice changing for our pts w #bladdercancer. @ascocancer.bsky.social #GU25
14.02.2025 17:07 β π 8 π 3 π¬ 1 π 0#MattGalsky updating results of #NIAGARA - great to see pathologic complete responses from neoadj gem-cis-durvalumab β durva improves disease free & overall survival even in those w pathCR. @ascocancer.bsky.social #GU25
14.02.2025 16:51 β π 10 π 4 π¬ 0 π 0#MattMilowsky with updated #Checkmate274 trial - adjuvant nivolumab after cystectomy improves time to recurrence & overall survival in #bladdercancer. Sets up ongoing #Alliance #MODERN trial! @ascocancer.bsky.social #GU25
14.02.2025 16:44 β π 6 π 4 π¬ 0 π 0Mevrometostat with enzalutamide vs enza alone with nice PSA responses and good PFS benefit! @ascocancer.bsky.social #GU25
14.02.2025 01:35 β π 3 π 0 π¬ 0 π 1